ABVC BioPharma, Inc. Deferred Revenue
ABVC BioPharma, Inc. (ABVC) had Deferred Revenue of $180.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2024-11-14
- 2024-09-30: Deferred Revenue $180.00K.
- 2024-06-30: Deferred Revenue $116.00K.
- 2023-09-30: Deferred Revenue $296.00K.
| Period end | Deferred Revenue |
|---|---|
| 2024-09-30 | $180.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $116.00K 10-Q · filed 2024-08-14 |
| 2023-09-30 | $296.00K 10-Q · filed 2024-11-14 |